1[1]Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndrome. Am J Cardiol, 2001, 88(8A): 10K ～ 15K.
2[2]Fuster V, Badimon L, Badimon J,et al. The pathogenesis of coronary artery disease and acute coronary syndromes. N Engl J Med,1992, 326(5) :245 ～ 250.
3[3]Laine P, Koartinen M, Pentica A,et al.Association between myocardial infarction and the mast cells in the adventitia of infarct-related coronary artery. Circulation, 1999, 99 (3):361 ～ 369.
4[4]Zhu J, Ouyyumi AA, Norman JE. Effects of total pathgen burden on coronary artery diseaserisk and C-reactive protein levels. Am J Car diol, 2000, 85(2): 140 ～ 146.
6[6]Wang ND, Pis J, Valencia R. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrion Examina tion Survey ( NHANES ) Ⅲ. Prev Cardiol,2001,4(3): 109 ～ 114.
7[7]Rider PM, Hennelens CH, Buring JE,et al. C-reactive protein and other markers of inflammation in the prediction cardiovascular disease in women. N Engl J Med, 2000, 342(12): 836 ～ 843.
8[8]Garcia-Moll X, Zouridakis E, Cole D, et al. C-reactive protein in patients with chronic stable angina:differences in baseline serum con cetration between women and men. Eur Heart J, 2000, 21(19):1598～ 1606.
9[9]Lindahl B, Toss H, Siegbahn A, et al. Mark ers of myocardiol damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med, 2000, 343 ( 16 ):1139.
10[10]Canthin B, Despres JP, Lamarche B, et al. Association of fibrinogen and lipoprotein(a) asa coronary heart disease risk factor in men (The Quebec Cardiovascular Study). Am JCardiol, 2002, 89(6) :662 ～ 666.
